Interventions for clinical and subclinical hypothyroidism in pregnancy.

BACKGROUND Over the last decade there has been enhanced awareness of the appreciable morbidity of thyroid dysfunction, particularly thyroid deficiency. Since treating clinical and subclinical hypothyroidism may reduce adverse obstetric outcomes, it is crucial to identify which interventions are safe and effective. OBJECTIVES To identify interventions used in the management of hypothyroidism and subclinical hypothyroidism in pregnancy and to ascertain the impact of these interventions on important maternal, fetal, neonatal and childhood outcomes. SEARCH STRATEGY We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (November 2009). SELECTION CRITERIA Randomised controlled trials (RCTs) that compared a pharmacological intervention for hypothyroidism and subclinical hypothyroidism in pregnancy with another intervention or placebo. DATA COLLECTION AND ANALYSIS Two review authors assessed trial eligibility and quality and extracted the data. MAIN RESULTS We included three RCTs of moderate risk of bias involving 314 women. In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0.61; 95% confidence interval (CI) 0.11 to 3.48) but did significantly reduce preterm birth by 72% (RR 0.28; 95% CI 0.10 to 0.80). One trial of 30 hypothyroid women compared levothyroxine doses, but only reported biochemical outcomes. A trial of 169 women compared the trace element selenomethionine (selenium) with placebo and no significant differences were seen for either pre-eclampsia (RR 1.44; 95% CI 0.25 to 8.38) or preterm birth (RR 0.96; 95% CI 0.20 to 4.61). None of the three trials reported on childhood neurodevelopmental delay.There was a non-significant trend towards fewer miscarriages with levothyroxine, and selenium showed some favourable impact on postpartum thyroid function and decreased incidence of moderate to advanced postpartum thyroiditis. AUTHORS' CONCLUSIONS Levothyroxine treatment of clinical hypothyroidism in pregnancy is already standard practice given the documented benefits from earlier non-randomised studies. Whether levothyroxine should be utilised in autoimmune and subclinical hypothyroidism remains to be seen, but it may prove worthwhile, given a possible reduction in preterm birth and miscarriage.Selenomethionine as an intervention in women with thyroid autoantibodies is promising, particularly in reducing postpartum thyroiditis. There is a probable low incidence of adverse outcomes from levothyroxine and selenomethionine. High-quality evidence is lacking and large-scale randomised trials are urgently needed in this area. Until evidence for or against universal screening becomes available, targeted thyroid function testing in pregnancy should be implemented in women at risk of thyroid disease and levothyroxine utilised in hypothyroid women.

[1]  S. Mandel,et al.  Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[3]  A. McElduff,et al.  Thyroid function tests and thyroid autoantibodies in an unselected population of women undergoing first trimester screening for aneuploidy , 2008, The Australian & New Zealand journal of obstetrics & gynaecology.

[4]  Douglas G. Altman,et al.  Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis , 2008 .

[5]  S. Mandel,et al.  CLINICAL PRACTICE GUIDELINE Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline , 2007 .

[6]  C. Spong,et al.  Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy , 2007, Obstetrics and gynecology.

[7]  D. Dazzi,et al.  The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  K. Leveno,et al.  Thyroid disease in pregnancy. , 2006, Obstetrics and gynecology.

[9]  D. Dazzi,et al.  Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. , 2006, The Journal of clinical endocrinology and metabolism.

[10]  F. Malone,et al.  Subclinical hypothyroidism and pregnancy outcomes , 2005 .

[11]  I. Greer,et al.  Outcomes of pregnancy complicated by thyroid disease , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  J. Lazarus.  Thyroid Disorders Associated with Pregnancy , 2005, Treatments in endocrinology.

[13]  J. Jameson,et al.  Disorders of the Thyroid Gland , 2005 .

[14]  M. Rotondi,et al.  Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. , 2004, European journal of endocrinology.

[15]  C. Clar,et al.  Iodine supplementation for preventing iodine deficiency disorders in children. , 2004, The Cochrane database of systematic reviews.

[16]  H. Gharib,et al.  Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[17]  R. Newcombe,et al.  Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. , 2002, The British journal of psychiatry : the journal of mental science.

[18]  Douglas G Altman,et al.  Meta-analyses involving cross-over trials: methodological issues. , 2002, International journal of epidemiology.

[19]  O. Levalle,et al.  Overt and subclinical hypothyroidism complicating pregnancy. , 2002, Thyroid : official journal of the American Thyroid Association.

[20]  S. Waisbren,et al.  "Maternal Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child" (1999), by James E. Haddow et al. , 2014 .

[21]  W. Wiersinga,et al.  Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy , 1999, Clinical endocrinology.

[22]  G. Delong,et al.  Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. , 1994, The New England journal of medicine.

[23]  E. Roti,et al.  Selenium administration does not cause thyroid insufficiency in subjects with mild iodine deficiency and sufficient selenium intake , 1993, Journal of endocrinological investigation.

[24]  J. Mestman,et al.  Perinatal outcome in hypothyroid pregnancies , 1993, Obstetrics and gynecology.

[25]  J. Dumont,et al.  Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population , 1992, Clinical endocrinology.

[26]  R. Stone.  Harrison's Principles of Internal Medicine , 1991 .

[27]  K. Leveno,et al.  Hypothyroidism Complicating Pregnancy , 1988, Obstetrics and gynecology.

[28]  J. Goldman.  Postpartum thyroid dysfunction. , 1986, Archives of internal medicine.

[29]  W. S. Jones,et al.  Thyroid function in human pregnancy. V. Incidence of maternal serum low butanol-extractable iodines and of normal gestational TBG and TBPA capacities; retardation of 8-month-old infants. , 1969, American journal of obstetrics and gynecology.

[30]  Liu,et al.  Iodised salt for preventing iodine deficiency disorders , 2022 .